搜索
Purple Biotech Ltd
PPBT添加自选
1.400USD
-0.010-0.71%
收盘 07-31 16:00（美东）报价延迟15分钟
13.01M总市值
亏损市盈率 TTM
关于 Purple Biotech Ltd 公司
Purple Biotech Ltd, formerly Kitov Pharma Ltd, is an Israel-based clinical-stage company that develops drugs that overcome tumor-immune evasion and drug resistancetreat pain. Main products of the Company is NT-219 i CM-24. CM-24 is a monoclonal antibody blockin and NT-219 is a small molecule bi-specific inhibitor of two key cancer resistance pathways. The Company is also the owner of Consensi, a fixed-dose combination of celecoxib and amlodipine besylate, for the simultaneous treatment of osteoarthritis pain and hypertension.
Purple Biotech Ltd简介
公司代码PPBT
公司名称Purple Biotech Ltd
上市日期Sep 03, 1978
CEOEfron (Gil)
员工数量9
证券类型Depository Receipt
年结日Sep 03
公司地址4 Oppenheimer St.
城市REHOVOT
上市交易所NASDAQ OMX - NASDAQ BASIC
国家Israel
邮编7670104
电话97239333121
网址https://purple-biotech.com/
公司代码PPBT
上市日期Sep 03, 1978
CEOEfron (Gil)
Purple Biotech Ltd公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Itzhak Israel
Mr. Itzhak Israel
Director
Director
--
--
Mr. Simcha Rock
Mr. Simcha Rock
Director
Director
--
--
Dr. Gil Ben-Menachem
Dr. Gil Ben-Menachem
Vice President - Business Development
Vice President - Business Development
--
--
Mr. Ido Agmon
Mr. Ido Agmon
Independent Director
Independent Director
--
--
Mr. Steven Steinberg
Mr. Steven Steinberg
Independent Director
Independent Director
--
--
Mr. Yisrael Gewirtz
Mr. Yisrael Gewirtz
Internal Auditor
Internal Auditor
--
--
Mr. Arie Weber
Mr. Arie Weber
Independent Director
Independent Director
--
--
Ms. Revital Stern-Raff
Ms. Revital Stern-Raff
Independent Director
Independent Director
--
--
Mr. Ran Tzror
Mr. Ran Tzror
Independent Director
Independent Director
--
--
Mr. Avraham Ben-Tzvi
Mr. Avraham Ben-Tzvi
General Counsel, Secretary
General Counsel, Secretary
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Itzhak Israel
Mr. Itzhak Israel
Director
Director
--
--
Mr. Simcha Rock
Mr. Simcha Rock
Director
Director
--
--
Dr. Gil Ben-Menachem
Dr. Gil Ben-Menachem
Vice President - Business Development
Vice President - Business Development
--
--
Mr. Ido Agmon
Mr. Ido Agmon
Independent Director
Independent Director
--
--
Mr. Steven Steinberg
Mr. Steven Steinberg
Independent Director
Independent Director
--
--
Mr. Yisrael Gewirtz
Mr. Yisrael Gewirtz
Internal Auditor
Internal Auditor
--
--
常见问题
Purple Biotech Ltd的前五大股东是谁？
Purple Biotech Ltd 的前五大股东如下：Mr. Itzhak Israel
有多少机构持有Purple Biotech Ltd(PPBT)的股份？
截至2026Q1，共有40家机构持有Purple Biotech Ltd的股份，合计持有的股份价值约为121.71K，占公司总股份的13.10%。与2025Q4相比，机构持股有所增加，增幅为86679.00。